Arkema Sa · EURONEXT:AKE

Arkema Sa — Q1 2014 Earnings Presentation

13 slides from Arkema Sa's earnings presentation, 2014

  1. Slide 1: 1st quarter 2014 results

    1st quarter 2014 results Thierry LEMONNIER CFO

  2. Slide 2: 1Q'14 highlights and key figures

    1Q’14 highlights and key figures Sales (€m) EBITDA (€m) 1,563 1,523 234 213 +0.7 % at constant scope and FX High basis of comparison +3.3 % volumes in Fluorogases in 1Q’13 (+7% EBITDA -2.6 % price excluding Fluorogases) mainly in Fluorogases 14.0 % EBITDA margin 1Q’13 1Q’14 1Q’13 1Q’14 EBITDA (€m) a

  3. Slide 3: Key drivers of 1Q'14 performance

    Key drivers of 1Q’14 performance Benefits from organic growth and innovation ● Acrylic acid capacity expansion in Clear Lake (US) ● Increased SAP production capacity by Sumitomo Seika in Carling (France) ● Coating Resins: start-up in China, ramp-up in Brazil and improving market conditions overall ●

  4. Slide 4: Projects announced in 1Q'14

    Projects announced in 1Q’14 Acquisition of acrylic assets Expansion of Organic Peroxides from Jurong in China* in China Creation of a manufacturing JV in Taixing x2 production capacity in Changshu with Jurong Chemical, leader in acrylic monomers in China To support increasing use of polymers in Asia

  5. Slide 5: Implementing 2014 top priorities

    Implementing 2014 top priorities Start Thiochemicals platform in Malaysia ● Commercial start-up expected in 2H’14 Finalize acquisition of Jurong’s acrylic assets ● Closing expected in summer 2014 for the acquisition of the 1st line of 160kt / year * ● Construction of 3rd line by Jurong on track Cont

  6. Slide 6: Sales bridge

    Sales bridge Sales (€m) Scope of FX rate – Volume Price business translation effect 1,563 +3.3% (2.6)% (1.2)% (2.1)% 1,523 ● Strong ● Pricing ● Changes in ● Mainly volumes and mix in consolidation strengthening in High Fluorogases scope* of euro versus Performance US dollar Materials (slow start in

  7. Slide 7: 1Q'14 key figures

    1Q’14 key figures In €m (except EPS) 1Q’13 1Q’14 variation Sales 1,563 1,523 -2.6% EBITDA 234 213 -9.0% EBITDA margin 15.0% 14.0% Recurring operating income 158 135 -14.6% Adjusted net income 97 88 -9.3% Net income (Group share) (30) 77 - Adjusted EPS 1.55 1.40 -9.7% 7

  8. Slide 8: High Performance Materials

    High Performance Materials In €m 1Q’13 1Q’14 variation Sales 448 474 +5.8 % EBITDA 70 83 +18.6 % EBITDA margin 15.6% 17.5% Recurring operating income 44 57 +29.5 % Strong start of the year compared to soft 1Q’13 with 19% EBITDA growth and 17.5% EBITDA margin €474m sales, up 7.9% at constant scope of

  9. Slide 9: Industrial Specialties

    Industrial Specialties In €m 1Q’13 1Q’14 variation Sales 539 496 -8.0 % EBITDA 104 72 -30.8 % EBITDA margin 19.3% 14.5% Recurring operating income 76 43 -43.4 % Lower results reflecting more challenging market conditions and very high basis of comparison in Fluorogases Excluding Fluorogases, perform

  10. Slide 10: Coating Solutions

    Coating Solutions In €m 1Q’13 1Q’14 variation Sales 562 547 -2.7 % EBITDA 77 73 -5.2 % EBITDA margin 13.7% 13.3% Recurring operating income 55 50 -9.1% Good resilience in a mixed environment €547m sales, up 1.4% at constant scope of business and FX ● +4.6% volumes excluding impact of the shutdown of

  11. Slide 11: Cash flow

    Cash flow In €m 1Q’14 EBITDA 213 • Usual seasonality of working capital Working capital variation * (152) • Should be largely reversed at year end Taxes (31) Cost of debt (11) Recurring capex (45) Others (5) Recurring cash flow (31) Non-recurring items in operating and (7) Including €(6)m restructur

  12. Slide 12: 2014 outlook

    2014 outlook Assumptions ● Moderate worldwide growth with contrasted market conditions by regions ● Stable €/US$ exchange rate versus 2013 (unchanged assumption despite unfavorable rate in 1Q’14) ● 2nd quarter 2014: • 2 very large maintenance turnarounds in Thiochemicals (Beaumont, US) and Technical

  13. Slide 13: Disclaimer

    Disclaimer The information disclosed in this document may contain forward-looking statements with respect to the financial condition, results of operations, business and strategy of Arkema. Such statements are based on management’s current views and assumptions that could ultimately prove inaccurate

Arkema — Q1 2014 Earnings Presentation on 6ix